Daiichi Sankyo: Venous Thromboembolism trials

The registry lists 14 Venous Thromboembolism studies with Daiichi Sankyo as lead sponsor. 0 are open to participants now and 12 have results posted.

Phase 1 2Phase 2 3Phase 3 7No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in EuropeCompletedNCT02943993Results posted
• Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary EmbolismCompletedNCT02923115Phase 1/2Results posted
• Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)CompletedNCT02798471Phase 3Results posted
• Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) StudyCompletedNCT02303431Phase 1Results posted
• Cancer Venous Thromboembolism (VTE)CompletedNCT02073682Phase 3Results posted
• Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower LimbsCompletedNCT01857583Phase 3Results posted
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedNCT01203098Phase 2Results posted
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedNCT01203072Phase 2Results posted
• A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedNCT01181167Phase 3Results posted
• Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture SurgeryCompletedNCT01181141Phase 3Results posted
• A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedNCT01181102Phase 3Results posted
• Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).CompletedNCT00986154Phase 3Results posted
• Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)CompletedNCT02952599
• Edoxaban Management in Diagnostic and Therapeutic ProceduresCompletedNCT02950168